Telstra Lifts Annual Earnings 8.3% as Mobile Revenue Soars
By Stuart Condie
SYDNEY--Telstra lifted annual earnings by 8.3% as increased travel helped to boost mobile revenue, and management outlined expectations for another rise in its 2024 fiscal year.
Australia's largest communications provider on Thursday reported earnings before interest, tax, depreciation and amortization for the 12 months through June of 7.86 billion Australian dollars (US$5.05 billion), compared with A$7.26 billion a year ago.
It posted A$8.0 billion in Ebitda on an underlying basis, meeting the top end of its A$7.8 billion-A$8.0 billion guidance range. The average analyst forecast had been A$7.91 billion, according to data compiled by FactSet.
The board held its final dividend at 8.5 Australian cents per share for a full-year payout of 17 Australian cents.
Statutory net profit rose by 14% to A$1.93 billion. Revenue rose 6.7% to A$22.70 billion.
Telstra said it expects underlying Ebitda of between A$8.2 billion and A$8.4 billion in fiscal 2024, which started July 1.
Write to Stuart Condie at stuart.condie@wsj.com
(END) Dow Jones Newswires
August 16, 2023 18:20 ET (22:20 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters